[email protected]... Traditional development models can't keep pace with the sheer number and diversity of rare conditions," said Rosa Canet-Avilés, PhD, CIRMChief Science Officer ... CIRM's RAPID program will fund two types of awards.
EIGHT, I'VE IDENTIFIED PEOPLE WITHIN CIRM OR THE ... THREE YEARS SINCE I GOT TO CIRM ... I THINK WHERE IT SAYS CIRM ... I THINK WHERE IT SAYS CIRM DIRECTOR OF FINANCE, WE ... CIRM - CaliforniaInstitute for ...
Leslie M ... “This trial is an exciting step for regenerative medicine and its potential to change the course of Huntington’s disease,” said Thompson, in a statement ... The clinical trial is expected to begin in mid-2026 ... .
With CIRM funding support, CureRare Disease will advance the program through late-stage preclinical development, GMP manufacturing, IND submission and Phase 1/2 clinical trial initiation ... For more information, visit www.cirm.ca.gov.